Intermediate Capital Group (ICG) is indirectly acquiring over 25% of the shares of Europe's largest radiopharmaceuticals provider Curium Pharma, HBI can reveal, after owner Capvest earlier pulled a majority sales process because of COVID-19.
HBI hears Synlab's private equity owner Cinven has mandated banks for an initial public offering, expected to take place next year. It will value Synlab at €5bn-6bn.
Buying France's third-largest private psychiatry group Inicea was a 'unique opportunity' for which a capital raise had to be used, Korian CFO Philippe Garin tells HBI, and international bolt-on acquisitions could follow. He discusses the deal's finances, COVID-19's impact on its regulatory environment, and one reason why Germany might have weathered the pandemic so much better than other countries.
It's been nearly two years since Australian-owned French hospital group Ramsay Sante completed the acquisition of Nordic-French acute care operator Capio. Contacts give HBI their assessment of how the integration is going and we take a look at Capio's performance since it was acquired.
Shares in pan-European elderly care group Korian dived by 10% after it announced a €400m capital raise to fund the acquisition of France's third-largest psychiatry provider Inicea from infrastructure investor Antin. But did it pay over-the-odds and do all shareholders support the capital raise? We talk to an analyst from Bryan, Garnier & Co.
HBI Intelligence is now forecasting that most European lab markets will be larger in 2020, than our pre-Covid forecasts. That is despite deep dips in March and April, with some groups thinking about firing two-thirds of their staff and defaulting on rent.
Dental markets have reopened following the pandemic peak but the impact may be felt for many months to come, not least because of a second wave winter. HBI has added new post-COVID market size data on the Intelligence platform based on conversations with operators. Most think new national lockdowns are unlikely but regional lockdowns, prolonged economic uncertainty for patients, and scared patients are all causing concern.
Ramsay Santé speaks to HBI about its plans to become France's first capitated healthcare provider as it imports Capio's model of primary care by opening five clinics in Q1 next year. CMO Francois Demesmay tells HBI that the funding model will allow the group to better leverage digital health innovations that focus on prevention and monitoring.
REIT Healthcare Activos Yield has listed on the Euronext Access Paris, while its sister company Healthcare Activos has made its first acquisition outside of Spain, CEO of the management company for both tells HBI. He talks us through the listing and the long-term impact of COVID-19 on the development of the Spanish care home sector.
COVID's second wave looks either imminent, or is already starting to hit in many jurisdictions. Wave one saw lockdowns and closures - and not all closures were temporary. Will wave two be any different? HBI has been talking to operators across EMEA to see if forewarned is forearmed, how they predict the next few months will go, and what lessons have been learned.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.